               SEQUENCE LISTING

<110> Linnane Pharm AB

<120> Novel Therapy

<130> P3048/WO

<150> GB1505382.0
<151> 2015-03-29

<160> 5

<170> BiSSAP 1.3.6

<210> 1
<211> 21
<212> RNA
<213> Artifical sequence


<220> 
<223> sense siRNA

<400> 1
guguuuacga ggaacccuat t                                              21


<210> 2
<211> 21
<212> RNA
<213> Artificial sequence


<220> 
<223> Antisense siRNA

<400> 2
uaggguuccu cguaaacacg g                                              21


<210> 3
<211> 187
<212> DNA
<213> Mus <mouse, genus>


<220> 
<223> Promoter sequence

<400> 3
gttcagagaa aggctgggct gcttgttgct ggctaaagga caaagggtaa gtttcaggaa     60

gcagaagagt gagcagatga aattcagcac tgggatcagg ggagtgtctg atttgcaaaa    120

ggaaagtgca aagacagctc ctcccttctg aggaaacgaa accaacagca gtccaagctc    180

agtcagc                                                              187


<210> 4
<211> 181
<212> DNA
<213> Mus <mouse, genus>


<220> 
<223> Promoter sequence

<400> 4
agatgagaga gcagtgaggg agagacagag actcgaattt ccggaggcta tttcagtttt     60

cttttccgtt ttgtgcaatt tcacttatga taccggccaa tgcttggttg ctattttgga    120

aactcccctt aggggatgcc cctcaactgg ccctataaag ggccagcctg agctgcagag    180

g                                                                    181


<210> 5
<211> 143
<212> DNA
<213> Mus <mouse, genus>


<220> 
<223> Promoter sequence

<400> 5
gataggagct taaataaaga gttttagaaa ctactaaaat gtaaatgaca taggaaaact     60

gaaagggaga agtgaaagtg ggaaattcct ctgaatagag agaggaccat ctcatataaa    120

taggccatac ccatggagaa agg                                            143


